Clovis Oncology’s Rubraca Rubraca passes over placebo from a patient perspective in Advanced Ovarian Cancer
Quality-adjusted progression free survival (QA-PFS) andquality-adjusted time without cancer related symptoms or toxicity(Q-TWiST) demonstrate the benefit of Rubraca maintenance treatment overplacebo from a patient perspective